Ovarian cancer is often referred to as the silent killer due to the advanced stage at which most cases are discovered. In the last 30 years, however, medical advancements have allowed us to wage a better fight against the disease, thereby increasing survival rates. As we enter into Ovarian Cancer Awareness Month, experts at Northwestern [...]
As Michigan observes September as National Ovarian Cancer Awareness Month, it is an opportunity to raise awareness of the risk factors and signs and symptoms of this deadly disease.
Ovarian cancer accounts for about 3% of all cancers among women and ranks 2nd among gynecological cancers. It causes more deaths than any other cancer of the [...]
Telik, Inc. (Nasdaq: TELK) today announced top-line results from an interrupted Phase 3 randomized study of Telcyta (canfosfamide HCL) in combination with pegylated liposomal doxorubicin (PLD) versus PLD alone in second-line therapy in platinum refractory, primary platinum resistant or secondary platinum resistant ovarian cancer.
On an intent-to-treat (ITT) basis for the 125 enrolled patients, the median [...]
A pilot study by researchers at The Ohio State University Comprehensive Cancer Center found that a novel blood test that screens for microRNAs can reliably detect ovarian cancer, even among patients who test negative for the deadly disease with the widely used CA-125 blood test.
“The early detection of ovarian cancer is the Holy Grail,” says [...]
A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers at The University of Texas M. D. Anderson Cancer Center report in the Nov. 15 issue of Cancer Research.
The research team also found that expression of the protein, known as PEA-15, [...]
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences.
The compounds could be less harmful than current cancer treatments on the market [...]
Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treatment of advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. The study, presented at the 12th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) in Bangkok in October, has [...]
Obese and non-obese ovarian cancer patients have the same overall survival rates.
Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center found ovarian cancer survival rates are the same for obese [...]
Ovarian Cancer Treatment and Cranberries
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a laboratory study. The scientists demonstrated in cell culture studies that human ovarian cancer cells resistant to platinum drugs became up to six times more sensitized to [...]
More than one-third of Canadian women believe that human papillomavirusvaccines prevent ovarian cancer, and about 25% of women believe routinePap tests detect ovarian cancer, a survey commissioned by Ovarian Cancer Canada found, Toronto’s Globe and Mailreports. HPV vaccines can prevent infection of some humanpapillomavirus strains that can lead to cervical cancer, and Pap testsare conducted [...]